Published: 28 December 2022
Author(s): Nadim Taheri, Arthur Mageau, Marie-Paule Chauveheid, Antoine Dossier, Fatima Farhi, Celine Mendes, Thomas Papo, Tiphaine Goulenok, Karim Sacre
Issue: March 2023
Section: Original article

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of manifestations affecting health-related quality of life [1]. In recent years recommendations have been standardized for diagnosis, treatment and target outcome in SLE [2,3]. Based on the 2019 EULAR recommendations, a set of 18 quality of care indicators (QIs) retained by a 12-expert panel have been proposed in order to assess and improve SLE patients care [4]. Tested in a cohort of 220 patients, higher adherence to QIs was associated with a reduced risk for a composite adverse outcome including SLE flare, hospitalization or damage accrual [4].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.